View Article |
Molecular analysis of fragile X syndrome (FXS) among Malaysian patients with developmental disability
Ernie Zuraida Ali1, Yusnita Yakob2, Norsiah Md Desa3, Taufik Ishak4, Zubaidah Zakaria5, Ngu, Lock-hock6, Keng, Wee-teik7.
Fragile X syndrome (FXS) is a neurodevelopmental disorder commonly found worldwide, caused by the silencing of fragile X mental retardation 1 (FMR1) gene on the X-chromosome. Most of the patients lost FMR1 function due to an expansion of cytosine-guanine-guanine (CGG) repeat at the 5’ untranslated region (5’UTR) of the gene. The purpose of this study is to identify the prevalence of FXS and characterize the FMR1 gene CGG repeats distribution among children with developmental disability in Malaysia. Genomic DNA of 2201 samples from different ethnicities (Malays, Chinese, Indian and others) of both genders were PCR-amplified from peripheral blood leukocytes based on specific primers at 5’UTR of FMR1 gene. Full mutations and mosaics were successfully identified by triple methylation specific PCR (ms-PCR) and subsequently verified with FragilEase kit. The findings revealed for the first time the prevalence of FXS full mutation in children with developmental disability in Malaysia was 3.5%, a slightly higher figure as compared to other countries. Molecular investigation also identified 0.2% and 0.4% probands have permutation and intermediate alleles, respectively. The CGG repeats length observation showed 95% of patients had normal alleles within 11 to 44 CGG repeats; with 29 repeats found most common among Malays and Indians while 28 repeats were most common among Chinese. In conclusion, this is the first report of prevalence and characterisation of CGG repeats that reflects genetic variability among Malaysian ethnic grouping.
Affiliation:
- Institute for Medical Research, Malaysia
- Institute for Medical Research, Malaysia
- Institute for Medical Research, Malaysia
- Institute for Medical Research, Malaysia
- Institute for Medical Research, Malaysia
- Hospital Kuala Lumpur, Malaysia
- Hospital Kuala Lumpur, Malaysia
|
|
Indexation |
Indexed by |
MyJurnal (2019) |
H-Index
|
0 |
Immediacy Index
|
0.000 |
Rank |
0 |
Indexed by |
Web of Science (JCR 2016) |
Impact Factor
|
0.640 |
Rank |
Q4 (Pathology) |
Indexed by |
Scopus (SCImago Journal Rankings 2016) |
Impact Factor
|
- |
Rank |
Q4 (Cell Biology) Q3 (Histology) Q3 (Pathology and Forensic Medicine) |
Additional Information |
0.279 (SJR) |
|
|
|